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Figure B: Calf Muscle Hypertrophy
Figure C: Myopathic Motor Units With Myotonic 
Discharges Showing A Typical Waxing And Waning 
Pattern On Needle Electromyography
Discussion:
Myotonic dystrophy type 1 is caused by a genetic 
defect composed of an expansion of 
cytosine-thymidine-guanine (CTG) repeats, resulting in 
a defect of the dystrophia myotonica protein kinase 
(DMPK) gene on chromosome 19 with a reduction of 
DMPK messenger RNA expression.5 Individual disorders 
exhibit distinct phenotypes with identifiable clinical 
features. Prenatal genetic testing is available for 
pregnancies at risk by analysis of DNA extracted from 
fetal cells obtained by amniocentesis at 15 to 18 
weeks gestation, or chorionic villus sampling at 10 to 
12 weeks gestation.[5] Additional historical detail, a 
brief physical examination and EMG characteristics are 
likely to provide the correct diagnosis or to suggest 
further investigations ruling out other neuromuscular 
disorders with myotonia e.g muscle channelopathies 
(paramyotonia congenital, sodium channel myotonia, 
hyperkalemic periodic paralysis), metabolic myopathies 
(Acid maltase deficiency, McArdle disease, Debrancher 
deficiency), toxic myopathies secondary to drugs 
(chloroquine, hydroxy chloroquine, statins, colchicine), 
endocrine myopathies (hypothyroidism, vitamin D 
deficiency) & inflammatory myopathies (polymyositis 
and dermatomyositis). There is no disease-modifying 
therapy available for the treatment of myotonic 
dystrophy. Thus, treatment is symptomatic. The 
systemic (non-neurological) manifestations can be 
better treated. Recommendations regarding 
management are based more on consensus and 
clinical experience than on evidence from randomized 
controlled trials. Ankle-foot orthoses are helpful in 
preventing foot-drop and enhancing gait stability. 
Muscle pain can be a persistent and troubling 
symptom. Pharmacologic agents that may be effective 
for this problem include nonsteroidal anti-inflammatory 
drugs, gabapentin, tricyclic antidepressants, mexiletine 
and low-dose glucocorticoids, such as oral prednisone 
5 mg on alternate days.6  The clinical experience of 
treating myotonia has involved a variety of 
medications,including phenytoin , mexiletine , 
procainamide , propafenone , flecainide, and 
carbamazepine, all of which are sodium channel 
blockers and share the potential to increase weakness 
while reducing myotonia.7 In two small seven-week 
double-blind randomized controlled trials involving 
patients with DM1, treatment with mexiletine (at either 
450 mg or 600 mg daily, both given in three divided 
doses) was superior to placebo for improvement in grip 
relaxation time. Mexiletine was well-tolerated in these 
trials and was not associated with any serious adverse 
effects or cardiac conduction abnormalities.8 Modafinil 
was evaluated in two trials that included a total of 60 
adults which suggested that modafinil was modestly 
beneficial for the treatment of daytime sleepiness in 
these patients.9 When sedation is necessary, use of a 
short acting agent such as propofol, and avoidance of 
long-acting sedatives such as the benzodiazepine and 
short-acting muscle relaxants such as atracurium are 
preferable to succinylcholine to minimize muscle 
activation.10  These patients are particularly susceptible 
to the respiratory depressant effects of 
benzodiazepines, barbiturates, anesthetics and 
opioids, so they should be used with caution. Also, 
while on statins there should be close monitoring of 
statin dose, potential myopathic symptoms, and serum 
creatinine kinase levels. Statin use should be 
abandoned in favor of another lipid management 
strategy if an increase in statin-related muscle 
symptoms and signs develop.[11] It is critical to assess 
the quality of sleep in such patients probing for whether 
there is nocturnal restlessness, unexplained 
awakenings, and loud snoring punctuated by 
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ABSTRACT:
INTRODUCTION: 
Myotonic dystrophy also known as (Steinert's disease) is a clinically and genetically heterogeneous multisystem 
disorder with a prevalence of 1 in 8000 in the general population. It is inherited as an autosomal dominant trait. It is 
characterized by myotonia, myopathy of voluntary and involuntary muscles, frontal baldness in men, cardiac 
conduction abnormalities, cataracts, intellectual deterioration and endocrinopathies. Affected men may have gonadal 
atrophy and infertility. On the other hand women are generally fertile. We report a case series of three individuals 
belonging to the same family presenting with characteristic features of myotonic dystrophy. The presentation of these 
cases depicts that this disease can lead to disability, loss of independence and social isolation especially in the elderly. 
They warrant adequate work up for diagnosis which may sometimes be extensive. Proper genetic counseling of the 
family is required regarding nature of the disease and with risks and prognosis.
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INTRODUCTION: Myotonia is defined clinically as the 
occurrence of “delayed relaxation of muscle after 
voluntary contraction or percussion.”1 It may be 
apparent from the first handshake, presenting with a 
delayed release of the hand. Myotonic dystrophy is a 
clinically and genetically heterogeneous multi-system 
disorder with a prevalence of 1 in 8000 in the general 
population inherited as an autosomal dominant trait.[1] 
It is characterized by myotonia, myopathy of voluntary 
and involuntary muscles, frontal baldness in men, 
cardiac conduction abnormalities, cataracts, 
intellectual deterioration and endocrinopathy. Men with 
this disorder have often gonadal atrophy and infertility. 
On the other hand women are generally fertile. During 
pregnancy their myopathy worsens, often causing 
severe obstetrical complications.2 Peri-natal mortality 
rate is 15-16% as compared to 1.9% in the near 
normal population and mainly accrediting to 
congenitally grieved fetuses together with 
complications occurring in pregnancy.3 Their children 
may develop congenital form of the disease with signs 
of myopathy in utero and have great difficulties in 
maintaining life functions after birth, together with 
other characteristic signs of this form: bilateral facial 
weakness, severe hypotonia, feeding difficulties, talipes 
equinovarus and mental retardation. Electromyography 
(EMG) findings often becomes a key element in the 
diagnosis. Myotonic potentials which are waxing and 
waning in characteristic are commonly recognized on 
needle EMG. Genetic tests are available for many of 
these disorders, although in some cases they are only 
available in specialized laboratories. The goals of 
treatment is to focus on managing the complications of 
the disease, particularly those relating to the 
cardiopulmonary system as these account for 70% of 
the deaths.4 Our patients were conservatively managed 
with Oral Phenytoin 100mg twice daily with physical 
rehabilitation as the mainstay of management. They 
are under regular follow up with dose-dependent 
improvement of symptoms & no apparent drug toxicity 
at any of the reported dosages.
CASE PRESENTATION
CASE 1: A 48 year old married male with no 
co-morbidities presents to our neurology department 
occasional awakenings and gasping for breath, all of 
which should suggest the presence of a sleep-related 
respiratory disorder and lead to further study with a 
poly somnographic evaluation that will reveal a more 
specific diagnosis.12 Noninvasive positive airway 
pressure ventilation (NIPPV) may be very helpful in 
correcting sleep apnea, improving hypoventilation, 
and assisting diaphragm weakness. Bilevel positive 
airway pressure ventilation (BiPAP) is better tolerated 
by patients with weakness of the chest wall and 
diaphragm who cannot overcome expiratory forces. 
Swallowing assessment is an important part of the 
management of these patients as dysphagia is a risk 
factor for aspiration pneumonia and poor nutrition.[13] 
Assessment by gastroenterology specialists may also 
be helpful. Intestinal pseudo-obstruction has been 
reported in patients with myotonic dystrophy13; it may 
be severe enough to require either a temporary or 
permanent ileostomy. In these patients 
electrocardiograms at least once a year should be 
done to screen for cardiac conduction disturbances. 
When arrhythmias are suspected clinically but are not 
detected on standard ECG,a 24-hour ambulatory ECG 
monitoring is suggested. Guidelines from the 
American College of Cardiology and American Heart 
Association (ACC/AHA) recommend pacemaker 
placement for third-degree or advanced second 
degree atrioventricular (AV) block in patients with 
myotonic dystrophy.14 Slit-lamp examination to detect 
cataracts is appropriate at the time of diagnosis and 
periodically thereafter, as dictated by symptoms in 
both DM1 and DM2 patients. In the congenital form 
of DM1, cataracts are uncommon before the age of 
ten.15 We started our patients on Oral Phenytoin 
100mg twice daily with physical rehabilitation as the 
mainstay of management. They are under regular 
follow up with dose-dependent improvement of 
symptoms & no apparent drug toxicity has been seen 
at any of the reported dosages. Although evidence is 
limited, life expectancy appears to be reduced for 
patients with DM1 of childhood or adult onset with 
respiratory and cardiac diseases being the most 
common causes of death.16 Younger age of onset, 
more severe muscle weakness, and cardiac 
arrhythmia may be associated with an increased risk 
of death.17 The complex manifestations of DM1, 
including neuromuscular, behavioral, emotional, and 
cognitive disturbances, contribute to suboptimal 
education levels, employment problems, and 
diminished income when compared with the general 
population, and accordingly compromise the daily 
activities and social roles of these patients. 
CONCLUSION
Myotonic dystrophies warrant adequate work up for 
diagnosis which may sometimes be extensive. Proper 
genetic counseling of the family is required regarding 
nature of the disease and with risks and prognosis. 
Behavioral therapy and physiotherapy is required to 
prevent social dependence. 
to show a significant difference in this regard. It was 
interesting to note that a multivariate logistic 
regression model used to assess the simultaneous 
influence of clinical, radiological and operative 
variables on the outcomes highlighted the importance 
of GCS as a critical factor to influence need for 
post-operative ventilation in these patients. 
with progressive muscle stiffness, difficulty in hand 
gripping and generalized fatigue for three months. His 
leg muscles appear very stiff at the initiation of 
walking but stiffness alleviates with continued activity. 
The effect lasts about five minutes. There is no history 
of backache, spine trauma, sphincteric involvement, 
dysphagia, dysarthria, shortness of breath, cyanosis 
or blurring of vision. He is a shop keeper by 
occupation with two children. He denies cigarette 
smoking or alcohol use. Family history is significant 
for similar complaints in his mother,younger brother 
and his son (Figure A). On physical examination he 
has frontal baldness, a narrow and elongated 
hatchet-shaped face with a transverse smile. There is 
bilateral ptosis with masseter and temporalis wasting. 
Diffuse calf muscle hypertrophy is seen in legs. 
Cranial nerves are normal. Percussion myotonia (on 
the right abductor pollicis brevis muscle), tongue and 
grip myotonia is positive. Tone is normal. Muscle 
power of the Medical Research Council (MRC) grade 
is 5/5 in both upper and lower limb muscle except 
bilateral handgrip which is of MRC grade 4/5. Reflexes 
are absent in upper and lower limbs with a flexor 
plantar response bilaterally. Sensory system is 
normal. Gait and coordination is intact. Rest of the 
systemic examination is unremarkable. 
CASE 2: An 11 year old boy was well till the age of 
five years with normal developmental milestones 
started to experience difficulty in running and playing 
at school, difficulty in handgrip and poor intellect. Her 
teachers complained of him being lazy and having a 
poor school performance. He is the son of case 1 
(Figure A). On physical examination he has frontal 
baldness, a narrow and elongated hatchet-shaped 
face with a transverse smile. There is bilateral ptosis 
with masseter and temporalis wasting.  Diffuse calf 
muscle hypertrophy is seen in legs. Cranial nerves are 
normal. Percussion myotonia (on the right abductor 
pollicis brevis muscle), tongue and grip myotonia is 
positive. Tone is normal. Muscle power of the Medical 
Research Council (MRC) grade is 5/5 in both upper 
and lower limb muscle except bilateral handgrip which 
is of MRC grade 4/5. Reflexes are absent in upper and 
lower limbs with a flexor plantar response bilaterally. 
Sensory system is normal. Gait and coordination is 
intact. Rest of the systemic examination is 
unremarkable.
CASE 3: A 44 year old un-married male with no 
co-morbidities presents with muscle stiffness usually 
beginning in the muscles of the hands, feet, neck and 
face for two years, which aggravates in cold weather. 
Whenever he starts to speak his tongue seemed stiff 
and he had difficulty in pronouncing words but it gets 
better after sometime. He is the younger brother of 
case 1 (Figure A). On examination he has frontal 
baldness, a narrow and elongated hatchet-shaped 
face with a transverse smile. There is bilateral ptosis 
with masseter and temporalis wasting.  Diffuse calf 
muscle hypertrophy is seen in legs (Figure B). Cranial 
nerves are normal. Percussion myotonia (on the right 
abductor pollicis brevis muscle), tongue and grip 
myotonia is positive. Tone is normal. Muscle power of 
the Medical Research Council (MRC) grade is 5/5 in 
both upper and lower limb muscle except bilateral 
handgrip which is of MRC grade 4/5. Reflexes are 
absent in upper and lower limbs with a flexor plantar 
response bilaterally. Sensory system is normal. Gait 
and coordination is intact. Rest of the systemic 
examination is unremarkable. All three cases 
underwent basic laboratory testing including serum 
levels of vitamin D, calcium, aldolase, creatine 
phosphokinase and thyroid hormones, which are 
normal. Echocardiography is unremarkable. Nerve 
conduction studies (NCS) is normal. EMG shows 
myopathic motor units with decrease amplitude and 
rapid recruitment along with typical ‘waxing and 
waning’ pattern consistent with myotonic discharges 
resembling a dive bomber sound. Muscle biopsy of 
the left rectus femoris shows fragments of skeletal 
muscle with focal area of fibrosis. 
Genetic testing was not done due to lack of availability 
and financial constraints.
Figure A: Family pedigree showing an ‘Autosomal 
dominant inheritance’
      
Figure B: Calf Muscle Hypertrophy
Figure C: Myopathic Motor Units With Myotonic 
Discharges Showing A Typical Waxing And Waning 
Pattern On Needle Electromyography
Discussion:
Myotonic dystrophy type 1 is caused by a genetic 
defect composed of an expansion of 
cytosine-thymidine-guanine (CTG) repeats, resulting in 
a defect of the dystrophia myotonica protein kinase 
(DMPK) gene on chromosome 19 with a reduction of 
DMPK messenger RNA expression.5 Individual disorders 
exhibit distinct phenotypes with identifiable clinical 
features. Prenatal genetic testing is available for 
pregnancies at risk by analysis of DNA extracted from 
fetal cells obtained by amniocentesis at 15 to 18 
weeks gestation, or chorionic villus sampling at 10 to 
12 weeks gestation.[5] Additional historical detail, a 
brief physical examination and EMG characteristics are 
likely to provide the correct diagnosis or to suggest 
further investigations ruling out other neuromuscular 
disorders with myotonia e.g muscle channelopathies 
(paramyotonia congenital, sodium channel myotonia, 
hyperkalemic periodic paralysis), metabolic myopathies 
(Acid maltase deficiency, McArdle disease, Debrancher 
deficiency), toxic myopathies secondary to drugs 
(chloroquine, hydroxy chloroquine, statins, colchicine), 
endocrine myopathies (hypothyroidism, vitamin D 
deficiency) & inflammatory myopathies (polymyositis 
and dermatomyositis). There is no disease-modifying 
therapy available for the treatment of myotonic 
dystrophy. Thus, treatment is symptomatic. The 
systemic (non-neurological) manifestations can be 
better treated. Recommendations regarding 
management are based more on consensus and 
clinical experience than on evidence from randomized 
controlled trials. Ankle-foot orthoses are helpful in 
preventing foot-drop and enhancing gait stability. 
Muscle pain can be a persistent and troubling 
symptom. Pharmacologic agents that may be effective 
for this problem include nonsteroidal anti-inflammatory 
drugs, gabapentin, tricyclic antidepressants, mexiletine 
and low-dose glucocorticoids, such as oral prednisone 
5 mg on alternate days.6  The clinical experience of 
treating myotonia has involved a variety of 
medications,including phenytoin , mexiletine , 
procainamide , propafenone , flecainide, and 
carbamazepine, all of which are sodium channel 
blockers and share the potential to increase weakness 
while reducing myotonia.7 In two small seven-week 
double-blind randomized controlled trials involving 
patients with DM1, treatment with mexiletine (at either 
450 mg or 600 mg daily, both given in three divided 
doses) was superior to placebo for improvement in grip 
relaxation time. Mexiletine was well-tolerated in these 
trials and was not associated with any serious adverse 
effects or cardiac conduction abnormalities.8 Modafinil 
was evaluated in two trials that included a total of 60 
adults which suggested that modafinil was modestly 
beneficial for the treatment of daytime sleepiness in 
these patients.9 When sedation is necessary, use of a 
short acting agent such as propofol, and avoidance of 
long-acting sedatives such as the benzodiazepine and 
short-acting muscle relaxants such as atracurium are 
preferable to succinylcholine to minimize muscle 
activation.10  These patients are particularly susceptible 
to the respiratory depressant effects of 
benzodiazepines, barbiturates, anesthetics and 
opioids, so they should be used with caution. Also, 
while on statins there should be close monitoring of 
statin dose, potential myopathic symptoms, and serum 
creatinine kinase levels. Statin use should be 
abandoned in favor of another lipid management 
strategy if an increase in statin-related muscle 
symptoms and signs develop.[11] It is critical to assess 
the quality of sleep in such patients probing for whether 
there is nocturnal restlessness, unexplained 
awakenings, and loud snoring punctuated by 
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INTRODUCTION: Myotonia is defined clinically as the 
occurrence of “delayed relaxation of muscle after 
voluntary contraction or percussion.”1 It may be 
apparent from the first handshake, presenting with a 
delayed release of the hand. Myotonic dystrophy is a 
clinically and genetically heterogeneous multi-system 
disorder with a prevalence of 1 in 8000 in the general 
population inherited as an autosomal dominant trait.[1] 
It is characterized by myotonia, myopathy of voluntary 
and involuntary muscles, frontal baldness in men, 
cardiac conduction abnormalities, cataracts, 
intellectual deterioration and endocrinopathy. Men with 
this disorder have often gonadal atrophy and infertility. 
On the other hand women are generally fertile. During 
pregnancy their myopathy worsens, often causing 
severe obstetrical complications.2 Peri-natal mortality 
rate is 15-16% as compared to 1.9% in the near 
normal population and mainly accrediting to 
congenitally grieved fetuses together with 
complications occurring in pregnancy.3 Their children 
may develop congenital form of the disease with signs 
of myopathy in utero and have great difficulties in 
maintaining life functions after birth, together with 
other characteristic signs of this form: bilateral facial 
weakness, severe hypotonia, feeding difficulties, talipes 
equinovarus and mental retardation. Electromyography 
(EMG) findings often becomes a key element in the 
diagnosis. Myotonic potentials which are waxing and 
waning in characteristic are commonly recognized on 
needle EMG. Genetic tests are available for many of 
these disorders, although in some cases they are only 
available in specialized laboratories. The goals of 
treatment is to focus on managing the complications of 
the disease, particularly those relating to the 
cardiopulmonary system as these account for 70% of 
the deaths.4 Our patients were conservatively managed 
with Oral Phenytoin 100mg twice daily with physical 
rehabilitation as the mainstay of management. They 
are under regular follow up with dose-dependent 
improvement of symptoms & no apparent drug toxicity 
at any of the reported dosages.
CASE PRESENTATION
CASE 1: A 48 year old married male with no 
co-morbidities presents to our neurology department 
occasional awakenings and gasping for breath, all of 
which should suggest the presence of a sleep-related 
respiratory disorder and lead to further study with a 
poly somnographic evaluation that will reveal a more 
specific diagnosis.12 Noninvasive positive airway 
pressure ventilation (NIPPV) may be very helpful in 
correcting sleep apnea, improving hypoventilation, 
and assisting diaphragm weakness. Bilevel positive 
airway pressure ventilation (BiPAP) is better tolerated 
by patients with weakness of the chest wall and 
diaphragm who cannot overcome expiratory forces. 
Swallowing assessment is an important part of the 
management of these patients as dysphagia is a risk 
factor for aspiration pneumonia and poor nutrition.[13] 
Assessment by gastroenterology specialists may also 
be helpful. Intestinal pseudo-obstruction has been 
reported in patients with myotonic dystrophy13; it may 
be severe enough to require either a temporary or 
permanent ileostomy. In these patients 
electrocardiograms at least once a year should be 
done to screen for cardiac conduction disturbances. 
When arrhythmias are suspected clinically but are not 
detected on standard ECG,a 24-hour ambulatory ECG 
monitoring is suggested. Guidelines from the 
American College of Cardiology and American Heart 
Association (ACC/AHA) recommend pacemaker 
placement for third-degree or advanced second 
degree atrioventricular (AV) block in patients with 
myotonic dystrophy.14 Slit-lamp examination to detect 
cataracts is appropriate at the time of diagnosis and 
periodically thereafter, as dictated by symptoms in 
both DM1 and DM2 patients. In the congenital form 
of DM1, cataracts are uncommon before the age of 
ten.15 We started our patients on Oral Phenytoin 
100mg twice daily with physical rehabilitation as the 
mainstay of management. They are under regular 
follow up with dose-dependent improvement of 
symptoms & no apparent drug toxicity has been seen 
at any of the reported dosages. Although evidence is 
limited, life expectancy appears to be reduced for 
patients with DM1 of childhood or adult onset with 
respiratory and cardiac diseases being the most 
common causes of death.16 Younger age of onset, 
more severe muscle weakness, and cardiac 
arrhythmia may be associated with an increased risk 
of death.17 The complex manifestations of DM1, 
including neuromuscular, behavioral, emotional, and 
cognitive disturbances, contribute to suboptimal 
education levels, employment problems, and 
diminished income when compared with the general 
population, and accordingly compromise the daily 
activities and social roles of these patients. 
CONCLUSION
Myotonic dystrophies warrant adequate work up for 
diagnosis which may sometimes be extensive. Proper 
genetic counseling of the family is required regarding 
nature of the disease and with risks and prognosis. 
Behavioral therapy and physiotherapy is required to 
prevent social dependence. 
to show a significant difference in this regard. It was 
interesting to note that a multivariate logistic 
regression model used to assess the simultaneous 
influence of clinical, radiological and operative 
variables on the outcomes highlighted the importance 
of GCS as a critical factor to influence need for 
post-operative ventilation in these patients. 
with progressive muscle stiffness, difficulty in hand 
gripping and generalized fatigue for three months. His 
leg muscles appear very stiff at the initiation of 
walking but stiffness alleviates with continued activity. 
The effect lasts about five minutes. There is no history 
of backache, spine trauma, sphincteric involvement, 
dysphagia, dysarthria, shortness of breath, cyanosis 
or blurring of vision. He is a shop keeper by 
occupation with two children. He denies cigarette 
smoking or alcohol use. Family history is significant 
for similar complaints in his mother,younger brother 
and his son (Figure A). On physical examination he 
has frontal baldness, a narrow and elongated 
hatchet-shaped face with a transverse smile. There is 
bilateral ptosis with masseter and temporalis wasting. 
Diffuse calf muscle hypertrophy is seen in legs. 
Cranial nerves are normal. Percussion myotonia (on 
the right abductor pollicis brevis muscle), tongue and 
grip myotonia is positive. Tone is normal. Muscle 
power of the Medical Research Council (MRC) grade 
is 5/5 in both upper and lower limb muscle except 
bilateral handgrip which is of MRC grade 4/5. Reflexes 
are absent in upper and lower limbs with a flexor 
plantar response bilaterally. Sensory system is 
normal. Gait and coordination is intact. Rest of the 
systemic examination is unremarkable. 
CASE 2: An 11 year old boy was well till the age of 
five years with normal developmental milestones 
started to experience difficulty in running and playing 
at school, difficulty in handgrip and poor intellect. Her 
teachers complained of him being lazy and having a 
poor school performance. He is the son of case 1 
(Figure A). On physical examination he has frontal 
baldness, a narrow and elongated hatchet-shaped 
face with a transverse smile. There is bilateral ptosis 
with masseter and temporalis wasting.  Diffuse calf 
muscle hypertrophy is seen in legs. Cranial nerves are 
normal. Percussion myotonia (on the right abductor 
pollicis brevis muscle), tongue and grip myotonia is 
positive. Tone is normal. Muscle power of the Medical 
Research Council (MRC) grade is 5/5 in both upper 
and lower limb muscle except bilateral handgrip which 
is of MRC grade 4/5. Reflexes are absent in upper and 
lower limbs with a flexor plantar response bilaterally. 
Sensory system is normal. Gait and coordination is 
intact. Rest of the systemic examination is 
unremarkable.
CASE 3: A 44 year old un-married male with no 
co-morbidities presents with muscle stiffness usually 
beginning in the muscles of the hands, feet, neck and 
face for two years, which aggravates in cold weather. 
Whenever he starts to speak his tongue seemed stiff 
and he had difficulty in pronouncing words but it gets 
better after sometime. He is the younger brother of 
case 1 (Figure A). On examination he has frontal 
baldness, a narrow and elongated hatchet-shaped 
face with a transverse smile. There is bilateral ptosis 
with masseter and temporalis wasting.  Diffuse calf 
muscle hypertrophy is seen in legs (Figure B). Cranial 
nerves are normal. Percussion myotonia (on the right 
abductor pollicis brevis muscle), tongue and grip 
myotonia is positive. Tone is normal. Muscle power of 
the Medical Research Council (MRC) grade is 5/5 in 
both upper and lower limb muscle except bilateral 
handgrip which is of MRC grade 4/5. Reflexes are 
absent in upper and lower limbs with a flexor plantar 
response bilaterally. Sensory system is normal. Gait 
and coordination is intact. Rest of the systemic 
examination is unremarkable. All three cases 
underwent basic laboratory testing including serum 
levels of vitamin D, calcium, aldolase, creatine 
phosphokinase and thyroid hormones, which are 
normal. Echocardiography is unremarkable. Nerve 
conduction studies (NCS) is normal. EMG shows 
myopathic motor units with decrease amplitude and 
rapid recruitment along with typical ‘waxing and 
waning’ pattern consistent with myotonic discharges 
resembling a dive bomber sound. Muscle biopsy of 
the left rectus femoris shows fragments of skeletal 
muscle with focal area of fibrosis. 
Genetic testing was not done due to lack of availability 
and financial constraints.
Figure A: Family pedigree showing an ‘Autosomal 
dominant inheritance’
  
      
Figure B: Calf Muscle Hypertrophy
Figure C: Myopathic Motor Units With Myotonic 
Discharges Showing A Typical Waxing And Waning 
Pattern On Needle Electromyography
Discussion:
Myotonic dystrophy type 1 is caused by a genetic 
defect composed of an expansion of 
cytosine-thymidine-guanine (CTG) repeats, resulting in 
a defect of the dystrophia myotonica protein kinase 
(DMPK) gene on chromosome 19 with a reduction of 
DMPK messenger RNA expression.5 Individual disorders 
exhibit distinct phenotypes with identifiable clinical 
features. Prenatal genetic testing is available for 
pregnancies at risk by analysis of DNA extracted from 
fetal cells obtained by amniocentesis at 15 to 18 
weeks gestation, or chorionic villus sampling at 10 to 
12 weeks gestation.[5] Additional historical detail, a 
brief physical examination and EMG characteristics are 
likely to provide the correct diagnosis or to suggest 
further investigations ruling out other neuromuscular 
disorders with myotonia e.g muscle channelopathies 
(paramyotonia congenital, sodium channel myotonia, 
hyperkalemic periodic paralysis), metabolic myopathies 
(Acid maltase deficiency, McArdle disease, Debrancher 
deficiency), toxic myopathies secondary to drugs 
(chloroquine, hydroxy chloroquine, statins, colchicine), 
endocrine myopathies (hypothyroidism, vitamin D 
deficiency) & inflammatory myopathies (polymyositis 
and dermatomyositis). There is no disease-modifying 
therapy available for the treatment of myotonic 
dystrophy. Thus, treatment is symptomatic. The 
systemic (non-neurological) manifestations can be 
better treated. Recommendations regarding 
management are based more on consensus and 
clinical experience than on evidence from randomized 
controlled trials. Ankle-foot orthoses are helpful in 
preventing foot-drop and enhancing gait stability. 
Muscle pain can be a persistent and troubling 
symptom. Pharmacologic agents that may be effective 
for this problem include nonsteroidal anti-inflammatory 
drugs, gabapentin, tricyclic antidepressants, mexiletine 
and low-dose glucocorticoids, such as oral prednisone 
5 mg on alternate days.6  The clinical experience of 
treating myotonia has involved a variety of 
medications,including phenytoin , mexiletine , 
procainamide , propafenone , flecainide, and 
carbamazepine, all of which are sodium channel 
blockers and share the potential to increase weakness 
while reducing myotonia.7 In two small seven-week 
double-blind randomized controlled trials involving 
patients with DM1, treatment with mexiletine (at either 
450 mg or 600 mg daily, both given in three divided 
doses) was superior to placebo for improvement in grip 
relaxation time. Mexiletine was well-tolerated in these 
trials and was not associated with any serious adverse 
effects or cardiac conduction abnormalities.8 Modafinil 
was evaluated in two trials that included a total of 60 
adults which suggested that modafinil was modestly 
beneficial for the treatment of daytime sleepiness in 
these patients.9 When sedation is necessary, use of a 
short acting agent such as propofol, and avoidance of 
long-acting sedatives such as the benzodiazepine and 
short-acting muscle relaxants such as atracurium are 
preferable to succinylcholine to minimize muscle 
activation.10  These patients are particularly susceptible 
to the respiratory depressant effects of 
benzodiazepines, barbiturates, anesthetics and 
opioids, so they should be used with caution. Also, 
while on statins there should be close monitoring of 
statin dose, potential myopathic symptoms, and serum 
creatinine kinase levels. Statin use should be 
abandoned in favor of another lipid management 
strategy if an increase in statin-related muscle 
symptoms and signs develop.[11] It is critical to assess 
the quality of sleep in such patients probing for whether 
there is nocturnal restlessness, unexplained 
awakenings, and loud snoring punctuated by 
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INTRODUCTION: Myotonia is defined clinically as the 
occurrence of “delayed relaxation of muscle after 
voluntary contraction or percussion.”1 It may be 
apparent from the first handshake, presenting with a 
delayed release of the hand. Myotonic dystrophy is a 
clinically and genetically heterogeneous multi-system 
disorder with a prevalence of 1 in 8000 in the general 
population inherited as an autosomal dominant trait.[1] 
It is characterized by myotonia, myopathy of voluntary 
and involuntary muscles, frontal baldness in men, 
cardiac conduction abnormalities, cataracts, 
intellectual deterioration and endocrinopathy. Men with 
this disorder have often gonadal atrophy and infertility. 
On the other hand women are generally fertile. During 
pregnancy their myopathy worsens, often causing 
severe obstetrical complications.2 Peri-natal mortality 
rate is 15-16% as compared to 1.9% in the near 
normal population and mainly accrediting to 
congenitally grieved fetuses together with 
complications occurring in pregnancy.3 Their children 
may develop congenital form of the disease with signs 
of myopathy in utero and have great difficulties in 
maintaining life functions after birth, together with 
other characteristic signs of this form: bilateral facial 
weakness, severe hypotonia, feeding difficulties, talipes 
equinovarus and mental retardation. Electromyography 
(EMG) findings often becomes a key element in the 
diagnosis. Myotonic potentials which are waxing and 
waning in characteristic are commonly recognized on 
needle EMG. Genetic tests are available for many of 
these disorders, although in some cases they are only 
available in specialized laboratories. The goals of 
treatment is to focus on managing the complications of 
the disease, particularly those relating to the 
cardiopulmonary system as these account for 70% of 
the deaths.4 Our patients were conservatively managed 
with Oral Phenytoin 100mg twice daily with physical 
rehabilitation as the mainstay of management. They 
are under regular follow up with dose-dependent 
improvement of symptoms & no apparent drug toxicity 
at any of the reported dosages.
CASE PRESENTATION
CASE 1: A 48 year old married male with no 
co-morbidities presents to our neurology department 
occasional awakenings and gasping for breath, all of 
which should suggest the presence of a sleep-related 
respiratory disorder and lead to further study with a 
poly somnographic evaluation that will reveal a more 
specific diagnosis.12 Noninvasive positive airway 
pressure ventilation (NIPPV) may be very helpful in 
correcting sleep apnea, improving hypoventilation, 
and assisting diaphragm weakness. Bilevel positive 
airway pressure ventilation (BiPAP) is better tolerated 
by patients with weakness of the chest wall and 
diaphragm who cannot overcome expiratory forces. 
Swallowing assessment is an important part of the 
management of these patients as dysphagia is a risk 
factor for aspiration pneumonia and poor nutrition.[13] 
Assessment by gastroenterology specialists may also 
be helpful. Intestinal pseudo-obstruction has been 
reported in patients with myotonic dystrophy13; it may 
be severe enough to require either a temporary or 
permanent ileostomy. In these patients 
electrocardiograms at least once a year should be 
done to screen for cardiac conduction disturbances. 
When arrhythmias are suspected clinically but are not 
detected on standard ECG,a 24-hour ambulatory ECG 
monitoring is suggested. Guidelines from the 
American College of Cardiology and American Heart 
Association (ACC/AHA) recommend pacemaker 
placement for third-degree or advanced second 
degree atrioventricular (AV) block in patients with 
myotonic dystrophy.14 Slit-lamp examination to detect 
cataracts is appropriate at the time of diagnosis and 
periodically thereafter, as dictated by symptoms in 
both DM1 and DM2 patients. In the congenital form 
of DM1, cataracts are uncommon before the age of 
ten.15 We started our patients on Oral Phenytoin 
100mg twice daily with physical rehabilitation as the 
mainstay of management. They are under regular 
follow up with dose-dependent improvement of 
symptoms & no apparent drug toxicity has been seen 
at any of the reported dosages. Although evidence is 
limited, life expectancy appears to be reduced for 
patients with DM1 of childhood or adult onset with 
respiratory and cardiac diseases being the most 
common causes of death.16 Younger age of onset, 
more severe muscle weakness, and cardiac 
arrhythmia may be associated with an increased risk 
of death.17 The complex manifestations of DM1, 
including neuromuscular, behavioral, emotional, and 
cognitive disturbances, contribute to suboptimal 
education levels, employment problems, and 
diminished income when compared with the general 
population, and accordingly compromise the daily 
activities and social roles of these patients. 
CONCLUSION
Myotonic dystrophies warrant adequate work up for 
diagnosis which may sometimes be extensive. Proper 
genetic counseling of the family is required regarding 
nature of the disease and with risks and prognosis. 
Behavioral therapy and physiotherapy is required to 
prevent social dependence. 
to show a significant difference in this regard. It was 
interesting to note that a multivariate logistic 
regression model used to assess the simultaneous 
influence of clinical, radiological and operative 
variables on the outcomes highlighted the importance 
of GCS as a critical factor to influence need for 
post-operative ventilation in these patients. 
with progressive muscle stiffness, difficulty in hand 
gripping and generalized fatigue for three months. His 
leg muscles appear very stiff at the initiation of 
walking but stiffness alleviates with continued activity. 
The effect lasts about five minutes. There is no history 
of backache, spine trauma, sphincteric involvement, 
dysphagia, dysarthria, shortness of breath, cyanosis 
or blurring of vision. He is a shop keeper by 
occupation with two children. He denies cigarette 
smoking or alcohol use. Family history is significant 
for similar complaints in his mother,younger brother 
and his son (Figure A). On physical examination he 
has frontal baldness, a narrow and elongated 
hatchet-shaped face with a transverse smile. There is 
bilateral ptosis with masseter and temporalis wasting. 
Diffuse calf muscle hypertrophy is seen in legs. 
Cranial nerves are normal. Percussion myotonia (on 
the right abductor pollicis brevis muscle), tongue and 
grip myotonia is positive. Tone is normal. Muscle 
power of the Medical Research Council (MRC) grade 
is 5/5 in both upper and lower limb muscle except 
bilateral handgrip which is of MRC grade 4/5. Reflexes 
are absent in upper and lower limbs with a flexor 
plantar response bilaterally. Sensory system is 
normal. Gait and coordination is intact. Rest of the 
systemic examination is unremarkable. 
CASE 2: An 11 year old boy was well till the age of 
five years with normal developmental milestones 
started to experience difficulty in running and playing 
at school, difficulty in handgrip and poor intellect. Her 
teachers complained of him being lazy and having a 
poor school performance. He is the son of case 1 
(Figure A). On physical examination he has frontal 
baldness, a narrow and elongated hatchet-shaped 
face with a transverse smile. There is bilateral ptosis 
with masseter and temporalis wasting.  Diffuse calf 
muscle hypertrophy is seen in legs. Cranial nerves are 
normal. Percussion myotonia (on the right abductor 
pollicis brevis muscle), tongue and grip myotonia is 
positive. Tone is normal. Muscle power of the Medical 
Research Council (MRC) grade is 5/5 in both upper 
and lower limb muscle except bilateral handgrip which 
is of MRC grade 4/5. Reflexes are absent in upper and 
lower limbs with a flexor plantar response bilaterally. 
Sensory system is normal. Gait and coordination is 
intact. Rest of the systemic examination is 
unremarkable.
CASE 3: A 44 year old un-married male with no 
co-morbidities presents with muscle stiffness usually 
beginning in the muscles of the hands, feet, neck and 
face for two years, which aggravates in cold weather. 
Whenever he starts to speak his tongue seemed stiff 
and he had difficulty in pronouncing words but it gets 
better after sometime. He is the younger brother of 
case 1 (Figure A). On examination he has frontal 
baldness, a narrow and elongated hatchet-shaped 
face with a transverse smile. There is bilateral ptosis 
with masseter and temporalis wasting.  Diffuse calf 
muscle hypertrophy is seen in legs (Figure B). Cranial 
nerves are normal. Percussion myotonia (on the right 
abductor pollicis brevis muscle), tongue and grip 
myotonia is positive. Tone is normal. Muscle power of 
the Medical Research Council (MRC) grade is 5/5 in 
both upper and lower limb muscle except bilateral 
handgrip which is of MRC grade 4/5. Reflexes are 
absent in upper and lower limbs with a flexor plantar 
response bilaterally. Sensory system is normal. Gait 
and coordination is intact. Rest of the systemic 
examination is unremarkable. All three cases 
underwent basic laboratory testing including serum 
levels of vitamin D, calcium, aldolase, creatine 
phosphokinase and thyroid hormones, which are 
normal. Echocardiography is unremarkable. Nerve 
conduction studies (NCS) is normal. EMG shows 
myopathic motor units with decrease amplitude and 
rapid recruitment along with typical ‘waxing and 
waning’ pattern consistent with myotonic discharges 
resembling a dive bomber sound. Muscle biopsy of 
the left rectus femoris shows fragments of skeletal 
muscle with focal area of fibrosis. 
Genetic testing was not done due to lack of availability 
and financial constraints.
Figure A: Family pedigree showing an ‘Autosomal 
dominant inheritance’
CASE 1  
CASE 2
CASE 3
      
Figure B: Calf Muscle Hypertrophy
Figure C: Myopathic Motor Units With Myotonic 
Discharges Showing A Typical Waxing And Waning 
Pattern On Needle Electromyography
Discussion:
Myotonic dystrophy type 1 is caused by a genetic 
defect composed of an expansion of 
cytosine-thymidine-guanine (CTG) repeats, resulting in 
a defect of the dystrophia myotonica protein kinase 
(DMPK) gene on chromosome 19 with a reduction of 
DMPK messenger RNA expression.5 Individual disorders 
exhibit distinct phenotypes with identifiable clinical 
features. Prenatal genetic testing is available for 
pregnancies at risk by analysis of DNA extracted from 
fetal cells obtained by amniocentesis at 15 to 18 
weeks gestation, or chorionic villus sampling at 10 to 
12 weeks gestation.[5] Additional historical detail, a 
brief physical examination and EMG characteristics are 
likely to provide the correct diagnosis or to suggest 
further investigations ruling out other neuromuscular 
disorders with myotonia e.g muscle channelopathies 
(paramyotonia congenital, sodium channel myotonia, 
hyperkalemic periodic paralysis), metabolic myopathies 
(Acid maltase deficiency, McArdle disease, Debrancher 
deficiency), toxic myopathies secondary to drugs 
(chloroquine, hydroxy chloroquine, statins, colchicine), 
endocrine myopathies (hypothyroidism, vitamin D 
deficiency) & inflammatory myopathies (polymyositis 
and dermatomyositis). There is no disease-modifying 
therapy available for the treatment of myotonic 
dystrophy. Thus, treatment is symptomatic. The 
systemic (non-neurological) manifestations can be 
better treated. Recommendations regarding 
management are based more on consensus and 
clinical experience than on evidence from randomized 
controlled trials. Ankle-foot orthoses are helpful in 
preventing foot-drop and enhancing gait stability. 
Muscle pain can be a persistent and troubling 
symptom. Pharmacologic agents that may be effective 
for this problem include nonsteroidal anti-inflammatory 
drugs, gabapentin, tricyclic antidepressants, mexiletine 
and low-dose glucocorticoids, such as oral prednisone 
5 mg on alternate days.6  The clinical experience of 
treating myotonia has involved a variety of 
medications,including phenytoin , mexiletine , 
procainamide , propafenone , flecainide, and 
carbamazepine, all of which are sodium channel 
blockers and share the potential to increase weakness 
while reducing myotonia.7 In two small seven-week 
double-blind randomized controlled trials involving 
patients with DM1, treatment with mexiletine (at either 
450 mg or 600 mg daily, both given in three divided 
doses) was superior to placebo for improvement in grip 
relaxation time. Mexiletine was well-tolerated in these 
trials and was not associated with any serious adverse 
effects or cardiac conduction abnormalities.8 Modafinil 
was evaluated in two trials that included a total of 60 
adults which suggested that modafinil was modestly 
beneficial for the treatment of daytime sleepiness in 
these patients.9 When sedation is necessary, use of a 
short acting agent such as propofol, and avoidance of 
long-acting sedatives such as the benzodiazepine and 
short-acting muscle relaxants such as atracurium are 
preferable to succinylcholine to minimize muscle 
activation.10  These patients are particularly susceptible 
to the respiratory depressant effects of 
benzodiazepines, barbiturates, anesthetics and 
opioids, so they should be used with caution. Also, 
while on statins there should be close monitoring of 
statin dose, potential myopathic symptoms, and serum 
creatinine kinase levels. Statin use should be 
abandoned in favor of another lipid management 
strategy if an increase in statin-related muscle 
symptoms and signs develop.[11] It is critical to assess 
the quality of sleep in such patients probing for whether 
there is nocturnal restlessness, unexplained 
awakenings, and loud snoring punctuated by 
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INTRODUCTION: Myotonia is defined clinically as the 
occurrence of “delayed relaxation of muscle after 
voluntary contraction or percussion.”1 It may be 
apparent from the first handshake, presenting with a 
delayed release of the hand. Myotonic dystrophy is a 
clinically and genetically heterogeneous multi-system 
disorder with a prevalence of 1 in 8000 in the general 
population inherited as an autosomal dominant trait.[1] 
It is characterized by myotonia, myopathy of voluntary 
and involuntary muscles, frontal baldness in men, 
cardiac conduction abnormalities, cataracts, 
intellectual deterioration and endocrinopathy. Men with 
this disorder have often gonadal atrophy and infertility. 
On the other hand women are generally fertile. During 
pregnancy their myopathy worsens, often causing 
severe obstetrical complications.2 Peri-natal mortality 
rate is 15-16% as compared to 1.9% in the near 
normal population and mainly accrediting to 
congenitally grieved fetuses together with 
complications occurring in pregnancy.3 Their children 
may develop congenital form of the disease with signs 
of myopathy in utero and have great difficulties in 
maintaining life functions after birth, together with 
other characteristic signs of this form: bilateral facial 
weakness, severe hypotonia, feeding difficulties, talipes 
equinovarus and mental retardation. Electromyography 
(EMG) findings often becomes a key element in the 
diagnosis. Myotonic potentials which are waxing and 
waning in characteristic are commonly recognized on 
needle EMG. Genetic tests are available for many of 
these disorders, although in some cases they are only 
available in specialized laboratories. The goals of 
treatment is to focus on managing the complications of 
the disease, particularly those relating to the 
cardiopulmonary system as these account for 70% of 
the deaths.4 Our patients were conservatively managed 
with Oral Phenytoin 100mg twice daily with physical 
rehabilitation as the mainstay of management. They 
are under regular follow up with dose-dependent 
improvement of symptoms & no apparent drug toxicity 
at any of the reported dosages.
CASE PRESENTATION
CASE 1: A 48 year old married male with no 
co-morbidities presents to our neurology department 
occasional awakenings and gasping for breath, all of 
which should suggest the presence of a sleep-related 
respiratory disorder and lead to further study with a 
poly somnographic evaluation that will reveal a more 
specific diagnosis.12 Noninvasive positive airway 
pressure ventilation (NIPPV) may be very helpful in 
correcting sleep apnea, improving hypoventilation, 
and assisting diaphragm weakness. Bilevel positive 
airway pressure ventilation (BiPAP) is better tolerated 
by patients with weakness of the chest wall and 
diaphragm who cannot overcome expiratory forces. 
Swallowing assessment is an important part of the 
management of these patients as dysphagia is a risk 
factor for aspiration pneumonia and poor nutrition.[13] 
Assessment by gastroenterology specialists may also 
be helpful. Intestinal pseudo-obstruction has been 
reported in patients with myotonic dystrophy13; it may 
be severe enough to require either a temporary or 
permanent ileostomy. In these patients 
electrocardiograms at least once a year should be 
done to screen for cardiac conduction disturbances. 
When arrhythmias are suspected clinically but are not 
detected on standard ECG,a 24-hour ambulatory ECG 
monitoring is suggested. Guidelines from the 
American College of Cardiology and American Heart 
Association (ACC/AHA) recommend pacemaker 
placement for third-degree or advanced second 
degree atrioventricular (AV) block in patients with 
myotonic dystrophy.14 Slit-lamp examination to detect 
cataracts is appropriate at the time of diagnosis and 
periodically thereafter, as dictated by symptoms in 
both DM1 and DM2 patients. In the congenital form 
of DM1, cataracts are uncommon before the age of 
ten.15 We started our patients on Oral Phenytoin 
100mg twice daily with physical rehabilitation as the 
mainstay of management. They are under regular 
follow up with dose-dependent improvement of 
symptoms & no apparent drug toxicity has been seen 
at any of the reported dosages. Although evidence is 
limited, life expectancy appears to be reduced for 
patients with DM1 of childhood or adult onset with 
respiratory and cardiac diseases being the most 
common causes of death.16 Younger age of onset, 
more severe muscle weakness, and cardiac 
arrhythmia may be associated with an increased risk 
of death.17 The complex manifestations of DM1, 
including neuromuscular, behavioral, emotional, and 
cognitive disturbances, contribute to suboptimal 
education levels, employment problems, and 
diminished income when compared with the general 
population, and accordingly compromise the daily 
activities and social roles of these patients. 
CONCLUSION
Myotonic dystrophies warrant adequate work up for 
diagnosis which may sometimes be extensive. Proper 
genetic counseling of the family is required regarding 
nature of the disease and with risks and prognosis. 
Behavioral therapy and physiotherapy is required to 
prevent social dependence. 
to show a significant difference in this regard. It was 
interesting to note that a multivariate logistic 
regression model used to assess the simultaneous 
influence of clinical, radiological and operative 
variables on the outcomes highlighted the importance 
of GCS as a critical factor to influence need for 
post-operative ventilation in these patients. 
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with progressive muscle stiffness, difficulty in hand 
gripping and generalized fatigue for three months. His 
leg muscles appear very stiff at the initiation of 
walking but stiffness alleviates with continued activity. 
The effect lasts about five minutes. There is no history 
of backache, spine trauma, sphincteric involvement, 
dysphagia, dysarthria, shortness of breath, cyanosis 
or blurring of vision. He is a shop keeper by 
occupation with two children. He denies cigarette 
smoking or alcohol use. Family history is significant 
for similar complaints in his mother,younger brother 
and his son (Figure A). On physical examination he 
has frontal baldness, a narrow and elongated 
hatchet-shaped face with a transverse smile. There is 
bilateral ptosis with masseter and temporalis wasting. 
Diffuse calf muscle hypertrophy is seen in legs. 
Cranial nerves are normal. Percussion myotonia (on 
the right abductor pollicis brevis muscle), tongue and 
grip myotonia is positive. Tone is normal. Muscle 
power of the Medical Research Council (MRC) grade 
is 5/5 in both upper and lower limb muscle except 
bilateral handgrip which is of MRC grade 4/5. Reflexes 
are absent in upper and lower limbs with a flexor 
plantar response bilaterally. Sensory system is 
normal. Gait and coordination is intact. Rest of the 
systemic examination is unremarkable. 
CASE 2: An 11 year old boy was well till the age of 
five years with normal developmental milestones 
started to experience difficulty in running and playing 
at school, difficulty in handgrip and poor intellect. Her 
teachers complained of him being lazy and having a 
poor school performance. He is the son of case 1 
(Figure A). On physical examination he has frontal 
baldness, a narrow and elongated hatchet-shaped 
face with a transverse smile. There is bilateral ptosis 
with masseter and temporalis wasting.  Diffuse calf 
muscle hypertrophy is seen in legs. Cranial nerves are 
normal. Percussion myotonia (on the right abductor 
pollicis brevis muscle), tongue and grip myotonia is 
positive. Tone is normal. Muscle power of the Medical 
Research Council (MRC) grade is 5/5 in both upper 
and lower limb muscle except bilateral handgrip which 
is of MRC grade 4/5. Reflexes are absent in upper and 
lower limbs with a flexor plantar response bilaterally. 
Sensory system is normal. Gait and coordination is 
intact. Rest of the systemic examination is 
unremarkable.
CASE 3: A 44 year old un-married male with no 
co-morbidities presents with muscle stiffness usually 
beginning in the muscles of the hands, feet, neck and 
face for two years, which aggravates in cold weather. 
Whenever he starts to speak his tongue seemed stiff 
and he had difficulty in pronouncing words but it gets 
better after sometime. He is the younger brother of 
case 1 (Figure A). On examination he has frontal 
baldness, a narrow and elongated hatchet-shaped 
face with a transverse smile. There is bilateral ptosis 
with masseter and temporalis wasting.  Diffuse calf 
muscle hypertrophy is seen in legs (Figure B). Cranial 
nerves are normal. Percussion myotonia (on the right 
abductor pollicis brevis muscle), tongue and grip 
myotonia is positive. Tone is normal. Muscle power of 
the Medical Research Council (MRC) grade is 5/5 in 
both upper and lower limb muscle except bilateral 
handgrip which is of MRC grade 4/5. Reflexes are 
absent in upper and lower limbs with a flexor plantar 
response bilaterally. Sensory system is normal. Gait 
and coordination is intact. Rest of the systemic 
examination is unremarkable. All three cases 
underwent basic laboratory testing including serum 
levels of vitamin D, calcium, aldolase, creatine 
phosphokinase and thyroid hormones, which are 
normal. Echocardiography is unremarkable. Nerve 
conduction studies (NCS) is normal. EMG shows 
myopathic motor units with decrease amplitude and 
rapid recruitment along with typical ‘waxing and 
waning’ pattern consistent with myotonic discharges 
resembling a dive bomber sound. Muscle biopsy of 
the left rectus femoris shows fragments of skeletal 
muscle with focal area of fibrosis. 
Genetic testing was not done due to lack of availability 
and financial constraints.
Figure A: Family pedigree showing an ‘Autosomal 
dominant inheritance’
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